Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

書誌詳細
主要な著者:	Karavitaki, N, Wass, J
フォーマット:	Conference item
出版事項:	2010

類似資料

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
著者:: Karavitaki, N, 等
出版事項: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
著者:: Karavitaki, N, 等
出版事項: (2013)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
著者:: Emilia Sbardella, 等
出版事項: (2016-10-01)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
著者:: Youngki Lee, 等
出版事項: (2014-09-01)

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
著者:: Shahzad Hira, 等
出版事項: (2012-10-01)

The outcome of macroprolactinomas resistant to dopamine agonists
著者:: Coculescu, M, 等
出版事項: (2005)

Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
著者:: Ashu Rastogi, 等
出版事項: (2012-01-01)

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
著者:: Bassam M Flamerz Arkawazi
出版事項: (2020-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
著者:: Herring, N, 等
出版事項: (2009)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
著者:: Soni, A, 等
出版事項: (2008)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
著者:: Lambert, K, 等
出版事項: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
著者:: Lambert, K, 等
出版事項: (2017)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
著者:: Souha S Elabd, 等
出版事項: (2018-02-01)

Cabergoline-induced mania in a patient of pituitary microadenoma
著者:: Satyakam Mohapatra, 等
出版事項: (2017-01-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
著者:: Ali S. Alzahrani, 等
出版事項: (2023-12-01)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
著者:: Reddy, R, 等
出版事項: (2011)

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
著者:: Michelle Maher, 等
出版事項: (2018-07-01)

Non-adenomatous pituitary tumours.
著者:: Karavitaki, N, 等
出版事項: (2009)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
著者:: Rogers, A, 等
出版事項: (2014)

Nonfunctioning pituitary adenomas: the Oxford experience.
著者:: Wass, J, 等
出版事項: (2009)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
著者:: Arnold, J, 等
出版事項: (2008)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
著者:: Arnold, JR, 等
出版事項: (2009)

The postoperative monitoring of nonfunctioning pituitary adenomas.
著者:: Wass, J, 等
出版事項: (2011)

The postoperative monitoring of nonfunctioning pituitary adenomas
著者:: Wass, J, 等
出版事項: (2011)

Treatment of pituitary tumors: history.
著者:: Thanabalasingham, G, 等
出版事項: (2005)

VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR
著者:: sylvia andrea araneda, 等
出版事項: (2015-02-01)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
著者:: Pankaj Agrawal, 等
出版事項: (2022-12-01)

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
著者:: Guadalupe Vargas-Ortega, 等
出版事項: (2022-07-01)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
著者:: Emre Bozkirli, 等
出版事項: (2013-01-01)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
著者:: Pratibha Singh, 等
出版事項: (2011-01-01)

The modern management of macroprolactinomas.
著者:: Grossman, A
出版事項: (1991)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
著者:: DL Goede, 等
出版事項: (2006-04-01)

Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction
著者:: Tania Sundra, 等
出版事項: (2024-03-01)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
著者:: Suliman, S, 等
出版事項: (2007)

No link to cardiac valvulopathy was seen in cabergoline treated patients
著者:: K Dharshini, 等
出版事項: (2012-10-01)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
著者:: Capatina, C, 等
出版事項: (2014)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
著者:: Barber, T, 等
出版事項: (2011)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
著者:: Pankaj Agrawal, 等
出版事項: (2023-03-01)

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
著者:: Fernandez, A, 等
出版事項: (2010)

Macroprolactinoma in an adolescent female with primary amenorrhoea
著者:: Ning Zhang, 等
出版事項: (2024-12-01)